当前位置: 首页 >> 检索结果
141. Efficacy and Safety of Drugs for Gastroparesis: Systematic Review and Network Meta-analysis.
作者: Maria Rosa Ingrosso.;Michael Camilleri.;Jan Tack.;Gianluca Ianiro.;Christopher J Black.;Alexander C Ford.
来源: Gastroenterology. 2023年164卷4期642-654页
Although there have been multiple drugs tested in gastroparesis, their relative efficacy and safety are unknown. We evaluated this in a network meta-analysis of randomized controlled trials (RCTs).
142. Prevalence of frailty among patients with inflammatory bowel disease and its association with clinical outcomes: a systematic review and meta-analysis.
作者: Xiangting Huang.;Mengmeng Xiao.;Benyue Jiang.;Xiuzheng Wang.;Xiaoyu Tang.;Xiao Xu.;Ying Chen.;Shixuan Wang.;Songbo Yan.;Siyi Wang.;Jiang Wang.;Pinglan Zhang.
来源: BMC Gastroenterol. 2022年22卷1期534页
Studies have reported frailty as an independent risk factor of mortality in patients with inflammatory bowel disease (IBD). However, no systematic review and meta-analysis has been conducted to determine the relationship of frailty and IBD. We aimed to investigate the prevalence of frailty in patients with IBD and the impact of frailty on the clinical prognosis of these patients.
143. Quality assessment of Clinical Practice Guidelines (CPG) for the diagnosis and treatment of inflammatory bowel disease using the AGREE II instrument: a systematic review.
作者: R Zambrano-Sánchez.;P Alvarez-Mena.;D Hidalgo.;C M Escobar Liquitay.;J V A Franco.;R W M Vernooij.;D Simancas-Racines.;A Viteri-García.;C Montesinos-Guevara.
来源: BMC Gastroenterol. 2022年22卷1期447页
The incidence and diagnosis of inflammatory bowel disease (IBD) has increased considerably in recent years. Many clinical practice guidelines (CPG) have been developed for the management of this disease across different clinical contexts, however, little evidence exists on their methodological quality. Therefore, we aimed to systematically evaluate the quality of CPGs for the diagnosis and treatment of IBD using the Appraisal of Guidelines for Research and Evaluation (AGREE II) instrument.
144. New-onset and relapsed liver diseases following COVID-19 vaccination: a systematic review.
作者: Saad Alhumaid.;Abbas Al Mutair.;Ali A Rabaan.;Fatemah M ALShakhs.;Om Prakash Choudhary.;Shin Jie Yong.;Firzan Nainu.;Amjad Khan.;Javed Muhammad.;Fadil Alhelal.;Mohammed Hussain Al Khamees.;Hussain Ahmed Alsouaib.;Ahmed Salman Al Majhad.;Hassan Redha Al-Tarfi.;Ali Hussain ALyasin.;Yaqoub Yousef Alatiyyah.;Ali Ahmed Alsultan.;Mohammed Essa Alessa.;Mustafa Essa Alessa.;Mohammed Ahmed Alissa.;Emad Hassan Alsayegh.;Hassan N Alshakhs.;Haidar Abdullah Al Samaeel.;Rugayah Ahmed AlShayeb.;Dalal Ahmed Alnami.;Hussain Ali Alhassan.;Abdulaziz Abdullah Alabdullah.;Ayat Hussain Alhmed.;Faisal Hussain AlDera.;Khalid Hajissa.;Jaffar A Al-Tawfiq.;Awad Al-Omari.
来源: BMC Gastroenterol. 2022年22卷1期433页
Liver diseases post-COVID-19 vaccination is extremely rare but can occur. A growing body of evidence has indicated that portal vein thrombosis, autoimmune hepatitis, raised liver enzymes and liver injuries, etc., may be potential consequence of COVID-19 vaccines.
145. Clinical effectiveness and safety of self-expandable implantable bulking agents for faecal incontinence: a systematic review.
The purpose of this systematic review is to evaluate whether self-expandable implantable vs non-self-expandable injectable bulking agents (second-line therapies) are equal/superior in terms of effectiveness (severity, quality of life [QoL]) and safety (adverse events) for faecal incontinence (FI).
146. Use of folic acid supplementation to halt and even reverse the progression of gastric precancerous conditions: a meta-analysis.
作者: Jing Lei.;Fugang Ren.;Wenyuan Li.;Xiaochuan Guo.;Qingsong Liu.;Hongjing Gao.;Yaobin Pang.;Yingjie He.;Jing Guo.;Jinhao Zeng.
来源: BMC Gastroenterol. 2022年22卷1期370页
Current data indicate that supplements such as folic acid and vitamin B may be beneficial in halting and even reversing atrophic gastritis, intestinal metaplasia and intraepithelial neoplasia, generally referred to as gastric precancerous conditions(GPC). However, there is no Meta-analysis article to evaluate the prevention and treatment of folic acid in the gastric precancerous conditions. We therefore conducted a meta-analysis to confirm the efficacy of folic acid in treating GPC.
147. Development, Validation, and Evaluation of the Pediatric Inflammatory Crohn's Magnetic Resonance Enterography Index From the ImageKids Study.
作者: Gili Focht.;Ruth Cytter-Kuint.;Mary-Louise C Greer.;Li-Tal Pratt.;Denise A Castro.;Peter C Church.;Thomas D Walters.;Jeffrey Hyams.;Dan Navon.;Javier Martin de Carpi.;Frank Ruemmele.;Richard K Russell.;Matan Gavish.;Anne M Griffiths.;Dan Turner.
来源: Gastroenterology. 2022年163卷5期1306-1320页
Cross-sectional imaging is important in the assessment of transmural inflammation in Crohn's disease (CD). Small bowel involvement is often more extensive in pediatric CD, requiring a panentering measuring tool. We undertook to develop a magnetic resonance enterography (MRE)-based index that would measure inflammation in all segments of the intestine, without rectal contrast.
148. Liver Stiffness on Magnetic Resonance Elastography and the MEFIB Index and Liver-Related Outcomes in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Individual Participants.
作者: Veeral Ajmera.;Beom Kyung Kim.;Kun Yang.;Abdul M Majzoub.;Tarek Nayfeh.;Nobuharu Tamaki.;Namiki Izumi.;Atsushi Nakajima.;Ramazan Idilman.;Mesut Gumussoy.;Digdem Kuru Oz.;Ayse Erden.;Natalie E Quach.;Xin Tu.;Xinlian Zhang.;Mazen Noureddin.;Alina M Allen.;Rohit Loomba.
来源: Gastroenterology. 2022年163卷4期1079-1089.e5页
Magnetic resonance elastography (MRE) is an accurate biomarker of liver fibrosis; however, limited data characterize its association with clinical outcomes. We conducted an individual participant data pooled meta-analysis on patients with nonalcoholic fatty liver disease to evaluate the association between liver stiffness on MRE and liver-related outcomes.
149. Economic evaluations of radioembolization with Itrium-90 microspheres in hepatocellular carcinoma: a systematic review.
作者: J C Alonso.;I Casans.;F M González.;D Fuster.;A Rodríguez.;N Sánchez.;I Oyagüez.;R Burgos.;A O Williams.;N Espinoza.
来源: BMC Gastroenterol. 2022年22卷1期326页
Transarterial radioembolization (TARE) with yttrium-90 microspheres is a clinically effective therapy for hepatocellular carcinoma (HCC) treatment. This study aimed to perform a systematic review of the available economic evaluations of TARE for the treatment of HCC.
150. Proactive Therapeutic Drug Monitoring Versus Conventional Management for Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis.
作者: Nghia H Nguyen.;Virginia Solitano.;Sudheer K Vuyyuru.;John K MacDonald.;Silje W Syversen.;Kristin Kaasen Jørgensen.;Eileen Crowley.;Christopher Ma.;Vipul Jairath.;Siddharth Singh.
来源: Gastroenterology. 2022年163卷4期937-949.e2页
Proactive therapeutic drug monitoring (TDM) has been proposed to improve outcomes in patients with inflammatory bowel disease (IBD) treated with tumor necrosis factor (TNF)α antagonists. We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) comparing proactive TDM with conventional management in patients with IBD.
151. Risk Factors for Abdominal Pain-Related Disorders of Gut-Brain Interaction in Adults and Children: A Systematic Review.
作者: Jasmine K Zia.;Adrienne Lenhart.;Pei-Lin Yang.;Margaret M Heitkemper.;Jason Baker.;Laurie Keefer.;Miguel Saps.;Callie Cuff.;Gregory Hungria.;Elizabeth J Videlock.;Lin Chang.
来源: Gastroenterology. 2022年163卷4期995-1023.e3页
Many studies have assessed risk factors of irritable bowel syndrome (IBS) and other abdominal pain-related disorders of gut-brain interaction (AP-DGBI); however, the role of these factors is unclear due to heterogeneous study designs. The aim of this systematic review was to extensively evaluate the literature and determine clinical risk and protective factors for the presence and persistence of AP-DGBI in children and adults.
152. Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis.
作者: Laurent Peyrin-Biroulet.;Perttu Arkkila.;Alessandro Armuzzi.;Silvio Danese.;Jordi Guardiola.;Jørgen Jahnsen.;Charles Lees.;Edouard Louis.;Milan Lukáš.;Walter Reinisch.;Xavier Roblin.;Minyoung Jang.;Han Geul Byun.;Dong-Hyeon Kim.;Sung Jeong Lee.;Raja Atreya.
来源: BMC Gastroenterol. 2022年22卷1期291页
There are limited comparative data for infliximab and vedolizumab in inflammatory bowel disease patients.
153. Risk of Cancer in Inflammatory Bowel Diseases: Umbrella Review and Reanalysis of Meta-analyses.
作者: Daniele Piovani.;Cesare Hassan.;Alessandro Repici.;Lorenza Rimassa.;Carmelo Carlo-Stella.;Georgios K Nikolopoulos.;Elio Riboli.;Stefanos Bonovas.
来源: Gastroenterology. 2022年163卷3期671-684页
To summarize the epidemiologic evidence and assess the validity of claimed associations of inflammatory bowel diseases (IBDs) with overall and site-specific cancer risk.
154. Hypomagnesemia in intestinal lymphangiectasia: a case report and review of the literature.
作者: Hao Feng.;Linfeng Zou.;Xiao Zhai.;Shengyu Zhang.;Jingnan Li.
来源: BMC Gastroenterol. 2022年22卷1期246页
Intestinal lymphangiectasia (IL) is a rare disease characterized by dilation of lymphatic vessels and leakage of lymphatic fluids into the intestinal lumen, causing depletion of lymphocytes, protein, lipids, fat-soluble vitamins, and electrolytes. Hypomagnesemia can occur in IL patients but is seldom discussed.
155. The diagnostic utility of endocytoscopy for the detection of gastric cancer: a systematic review and meta-analysis.
作者: Andrew Canakis.;Shivanand Bomman.;Benjamin Twery.;Nevin Varghese.;Byung Ji.;Justin Canakis.;Eric M Goldberg.
来源: Minerva Gastroenterol (Torino). 2024年70卷2期225-230页
Endocytoscopy (ECS) is an evolving technology that utilizes ultra-high power magnification for real time cellular imaging without the need for physical biopsy. Its application for gastric cancer (GC) detection is not well evaluated at the current time, but there is potential that ECS can make a real time histopathological diagnosis to differentiate neoplastic from benign lesions. We aimed to investigate the diagnostic utility of ECS for GC detection.
156. The role of faecal calprotectin in diagnosis and staging of colorectal neoplasia: a systematic review and meta-analysis.
作者: Fiona A Ross.;James H Park.;David Mansouri.;Emilie Combet.;Paul G Horgan.;Donald C McMillan.;Campbell S D Roxburgh.
来源: BMC Gastroenterol. 2022年22卷1期176页
The presence of inflammation is a key hallmark of cancer and, plays an important role in disease progression and survival in colorectal cancer (CRC). Calprotectin detected in the faeces is a sensitive measure of colonic inflammation. The role of FC as a diagnostic test that may categorise patients by risk of neoplasia is poorly defined. This systematic review and meta-analysis aims to characterise the relationship between elevations of FC and colorectal neoplasia.
157. Sleeve gastrectomy versus Roux-en-Y Gastric Bypass for remission of type 2 diabetes mellitus at 1, 3 and 5 years: a systematic review and meta-analysis.
作者: Kaneez Fatima.;Sabeeh K Farooqui.;Izma Ajaz.;Shaikh T Ali.;Nida Hashmi.;Sara Nadeem.;Sameed A Ghazi.;Shahzeb H Kaleem.;Fatima S Bozdar.;Mushk Noorani.
来源: Minerva Gastroenterol (Torino). 2022年68卷4期450-458页
Sleeve gastrectomy (SG) and Roux-en-Y Gastric Bypass (RYGB) are the two procedures used in the management of patient with obesity and type 2 diabetes mellitus (T2DM); however, it is still unclear which of the two is more efficient in the remission of type-2 diabetes mellitus.
158. Are gastrointestinal symptoms associated with higher risk of Mortality in COVID-19 patients? A systematic review and meta-analysis.
Gastrointestinal symptoms have been reported in patients with COVID-19. Several clinical investigations suggested that gastrointestinal symptoms were associated with disease severity of COVID-19. However, the relevance of gastrointestinal symptoms and mortality of COVID-19 remains largely unknown. We aim to investigate the relationship between gastrointestinal symptoms and COVID-19 mortality.
159. Systematic review and meta-analysis: the advantage of endoscopic Mayo score 0 over 1 in patients with ulcerative colitis.
作者: Angelo Viscido.;Marco Valvano.;Gianpiero Stefanelli.;Annalisa Capannolo.;Chiara Castellini.;Eugenia Onori.;Antonio Ciccone.;Filippo Vernia.;Giovanni Latella.
来源: BMC Gastroenterol. 2022年22卷1期92页
Mucosal healing (MH) evaluated by endoscopy is a novel target of therapy in UC as it is associated with improved long-term outcomes. It is defined based on the Mayo endoscopic score (MES), but it is still to define whether a value of MES 0 or 1 should be the target. The purpose of this paper is to present the results of a systematic review with meta-analysis which compares long-term outcomes of patients in steroid-free clinical remission with MES 0 with those with MES 1.
160. A Systematic Review and Meta-analysis of Dietary Interventions Modulating Gut Microbiota and Cardiometabolic Diseases-Striving for New Standards in Microbiome Studies.
作者: Ilias Attaye.;Moritz V Warmbrunn.;Aureline N A F Boot.;Suze C van der Wolk.;Barbara A Hutten.;Joost G Daams.;Hilde Herrema.;Max Nieuwdorp.
来源: Gastroenterology. 2022年162卷7期1911-1932页
Cardiometabolic diseases (CMDs) have shared properties and causes. Insulin resistance is a risk factor and characteristic of CMDs and has been suggested to be modulated by plasma metabolites derived from gut microbiota (GM). Because diet is among the most important modulators of GM, we performed a systematic review of the literature to assess whether CMDs can be modulated via dietary interventions targeting the GM.
|